ENV-101 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10 (month) in 2mo
ESTIMATED |
READOUT
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
Phase 2 · Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease |
Endeavor Biomedicines, Inc. | ENV-101 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|